期刊
SURGERY TODAY
卷 -, 期 -, 页码 -出版社
SPRINGER
DOI: 10.1007/s00595-023-02714-9
关键词
Liver metastasis; Pancreatic neuroendocrine tumor; Transarterial chemoembolization
类别
This study reviewed 48 transarterial chemoembolization (TACE) procedures performed on 11 patients with pancreatic neuroendocrine tumor (PanNEN) liver metastases, including 16 TACE procedures for 3 patients with a history of biliary-enteric anastomosis. The overall tumor objective response rate was 94%. The incidence of significant complications and time to untreatable progression were evaluated in patients with and without a history of biliary-enteric anastomosis.
Transarterial chemoembolization (TACE) is performed for pancreatic neuroendocrine tumor (PanNEN) liver metastases; however, the safety and efficacy of TACE procedures, especially for patients who have undergone previous pancreatic surgery, have not been established. We reviewed 48 TACE procedures (1-6 procedures/patient) performed on 11 patients with PanNEN liver metastases, including 16 TACE procedures (4-6 procedures/patient) for 3 patients with a history of biliary-enteric anastomosis. The overall tumor objective response rate was 94%. The incidence of Clavien-Dindo grade & GE; 2 complications was 1/16 (6%) and 1/32 (3%), and the median time to untreatable progression was 31 (14-41) and 27 (2-60) months among patients with and without a history of biliary-enteric anastomosis, respectively. Although validation is needed in future studies, our experiences have shown that TACE treatment is a viable treatment option for PanNEN liver metastases, even after biliary-enteric anastomosis with experienced teams and careful patient follow-up.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据